These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27591007)

  • 1. Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
    Kim JH; Nam G
    Bioorg Med Chem; 2016 Nov; 24(21):5028-5035. PubMed ID: 27591007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
    Kim JH; Keum G; Chung H; Nam G
    Eur J Med Chem; 2016 Nov; 123():665-672. PubMed ID: 27517811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
    Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and diabetic neuropathic pain-alleviating effects of 2N-(pyrazol-3-yl)methylbenzo[d]isothiazole-1,1-dioxide derivatives.
    Hong JR; Choi YJ; Keum G; Nam G
    Bioorg Med Chem; 2017 Sep; 25(17):4677-4685. PubMed ID: 28720324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
    Kang B; Oh JA; Lee JY; Rhim H; Yune TY; Park Choo HY
    Bioorg Med Chem; 2015 Sep; 23(18):6166-72. PubMed ID: 26296911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca
    Wall MJ; Subasinghe NL; Winters MP; Lubin ML; Finley MFA; Qin N; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3780-3783. PubMed ID: 30337231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
    Son WS; Jeong KS; Lim SM; Pae AN
    Bioorg Med Chem Lett; 2019 May; 29(10):1168-1172. PubMed ID: 30928197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel series of pyrazolylpiperidine N-type calcium channel blockers.
    Subasinghe NL; Wall MJ; Winters MP; Qin N; Lubin ML; Finley MF; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4080-3. PubMed ID: 22608964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.
    Park JE; Ji WK; Jang JW; Pae AN; Choi K; Choi KH; Kang J; Roh EJ
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1887-90. PubMed ID: 23395659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
    Du Nguyen H; Okada T; Kitamura S; Yamaoka S; Horaguchi Y; Kasanami Y; Sekiguchi F; Tsubota M; Yoshida S; Nishikawa H; Kawabata A; Toyooka N
    Bioorg Med Chem; 2018 Aug; 26(15):4410-4427. PubMed ID: 30031654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
    Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
    Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles.
    Yonetoku Y; Kubota H; Okamoto Y; Ishikawa J; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2006 Aug; 14(15):5370-83. PubMed ID: 16616503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and evaluation of Ca
    Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
    Lee JH; Seo SH; Lim EJ; Cho NC; Nam G; Kang SB; Pae AN; Jeong N; Keum G
    Eur J Med Chem; 2014 Mar; 74():246-57. PubMed ID: 24480356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
    Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.